New mRNA Flu Shot Available for Adults Aged 50 and Older

• The FDA approved a new mRNA flu shot for adults aged 50 and older.
• The new shot, mFLUSIVA, was developed by Cambridge-based Moderna.
• It was approved in August for people aged 50 to 64.
• Some local pharmacies may have difficulty supplying the new shot.
• HealthLink is exploring how the new mRNA flu shot compares to the traditional flu shot.